Company intelligence / Profile preview
Zhuhai Beihai Biotech
Zhuhai, Guangdong, Chinacn.linkedin.com ↗
- Ownership
- Private
- Employees
- ~75
- Development stage
- Other
01
Overview
Zhuhai Beihai Biotech is an innovative biopharmaceutical company focused on developing novel oncology drugs and pain management therapies. Its lead product, BEIZRAY (albumin-solubilized docetaxel), received FDA approval in October 2024 as the first improved docetaxel formulation without synthetic excipients, offering significant clinical advantages. The company has over ten differentiated drug development pipelines with multiple assets at various stages from preclinical to commercial. It has secured more than thirty patents globally and nine IND approvals in China and the US. A major partnership with Zydus Lifesciences grants exclusive US commercialization rights for BEIZRAY.
- Therapeutic areas
- OncologyNeurology
- Modalities
- Small moleculesPeptide-drug conjugates (PDC)Albumin-solubilized formulations
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →03
Partnerships
Zydus Lifesciences/Zydus Pharmaceuticals USA—exclusive licensing/commercialization of BEIZRAY in the US market.
Beyond the preview
Go deeper on Zhuhai Beihai Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zhuhai Beihai Biotech.